On July 24, Department of Cardiovascular Surgery of the First Affiliated Hospital of Xi 'an Jiaotong University (XJTU) was approved as the first-batch "National Demonstration Center for Adsorption-type Extracorporeal Life Support Technology" in China at the 5th Annual Meeting of Chinese Society of Extracorporeal Life Support (CSECLS 20...
On July 23, Professor Ma Ding, Academician of Chinese Academy of Engineering and Director of Department of Obstetrics and Gynecology of Tongji Hospital of Huazhong University of Science and Technology, led a team to visit the First Affiliated Hospital of Xi’an Jiaotong University (XJTU) for guidance and exchange and boost the discipli...
On July 9, 2021, the research outcomes of a multi-center large-scale clinical study (RESOLVE) of locally advanced gastric cancer led by Chinese experts were online published in The Lancet Oncology (impact factor 41.316), a top-notched international oncology journal. The RESOLVE study entitled "Perioperative or postoperative adjuvant ...
On July 17, 2021, the research outcomes of an article entitled “Icotinib versus chemotherapy as adjuvant treatment for stage II-IIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial”, jointly carried out by Professor Zhou Caicun from Shanghai Pulmonary Hospital affiliated to Tongji University ...
From July 16 to 18, the semi-finals and finals of the 4th (2021) China Medical Devices Design and Entrepreneurship Competition-Minimally Invasive Devices with the theme of “Intelligent Manufacturing for Better Future” were held in Tonglu, Zhejiang province. Online registration of the competition was launched on March 5, and a total o...
